跳转至内容
Merck
CN

ABS1513-I-AF488

Anti-phospho-Ubiquitin Antibody (Ser65), Alexa Fluor 488 Conjugate

from rabbit, ALEXA FLUOR 488

别名:

Ubiqutin, Ser65 phosphorylated, Ub, Ser65 phosphorylated

登录 查看组织和合同定价。

选择尺寸


关于此项目

eCl@ss:
32160702
UNSPSC Code:
12352203
NACRES:
NA.46
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Anti-phospho-Ubiquitin Antibody (Ser65), Alexa Fluor 488 Conjugate, from rabbit, ALEXA FLUOR 488

biological source

rabbit

conjugate

ALEXA FLUOR 488

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human

species reactivity (predicted by homology)

guinea pig (based on 100% sequence homology), bovine (based on 100% sequence homology), hamster (based on 100% sequence homology), mouse (based on 100% sequence homology), sheep (based on 100% sequence homology), rat (based on 100% sequence homology), nonhuman primates (based on 100% sequence homology), horse (based on 100% sequence homology)

technique(s)

immunocytochemistry: suitable

NCBI accession no.

UniProt accession no.

shipped in

ambient

target post-translational modification

phosphorylation (pSer65)

Quality Level

Gene Information

human ... UBB(7314)

Analysis Note

Evaluated by Immunocytochemistry in PINK1-expressing HeLa cells with or without CCCP treatment.

Immunocytochemistry Analysis: A 1:100 dilution of this antibody detected CCCP treatment-induced ubiquitin Ser65 phosphorylation in PINK1-expressing HeLa cells.

Application

Detect ubiquitin Ser65 phosphorylation using this rabbit polyclonal Anti-phospho-Ubiquitin (Ser65) Antibody, Alexa Fluor 488 Conjugate, Cat. No. ABS1513-I-AF488, validated for use in Immunocytochemistry.
Research Category
Signaling
The unconjugated antibody (Cat. No. AB1513-I) is also available for Immunocytochemistry and Western Blotting applications.

Biochem/physiol Actions

Target specificity was verified using the unconjugated antibody (ABS1513-I). Only Ser65-phosphorylated ubiquitin (Ub) and ubiquitinated proteins (including oligoUb and polyUb) containing Ser65-phosphorylated ubiquitin were detected. This antibody exhibits no reactivity toward Ub or ubiquitinated proteins in the absence of Ub Ser65 phosphorylation.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Ubiqutin (Ub) is initially produced as a 229-a.a. Polyubiquitin-B (UniProt P0CG47) precursor protein encoded by the UBB gene (Gene ID 7314) or a 685-a.a. Polyubiquitin-C precursor protein (UniProt P0CG48) encoded by the UBC gene (Gene ID 7316) in human. The C-termini of Polyubiquitin-B (Cys229) and Polyubiquitin-C (Val685) are post-translationally removed, followed by additional posttranslational cleavages to yield multiple copies of idential 76-amino acid ubiquitin (also known as high mobility group nonhistone protein HMG-20) molecules (three copies per Polyubiquitin-B and nine copies per Polyubiquitin-C). Covalent modifications of target proteins via different Ub Lys residues are well documented events during cellular DNA repair, ER-associated degradation (ERAD), transcription activation, lysosomal and proteasomal degradation. PINK1 (PTEN induced putative kinase 1) is a Ser/Thr kinase that specifically accumulates in depolarized mitochondria, where it acts as a positive regulator of parkin (Park2) E3 ubiquitin (Ub) ligase activity by phosphorylating Ub at Ser65 as well as the corresponding Ser residue in parkin N-terminal Ub-like (UBL) domain. Phosphorylated Ub interacts with phosphorylated parkin at its GINGO0 domain in an allosteric manner, inducing a conformation change and exposing parkin RING2 domain catalytic cysteine for full ligase activity. NMR based conformation study reveals that Ser65-phosphorylated Ub exists in two conformations in solution. The major conformation displays altered surface properties, while the second phosphoUb conformation exhibits a retracted C-terminal tail by two residues into the Ub core. Ub Ser65 phosphorylation has little effect toward E1-mediated E2 charging and mainly affects the discharging of E2 enzymes to form polyUb chains. In addition, the majority of deubiquitinases (DUBs), including USP8, USP15 and USP30, are shown to exhibit impaired activity against Lys63-linked poly-phosphoUb.
~17/8 kDa (dimer/monomer) and ~45-250 kDa observed. 8.565/17.112/25.66/34.21 kDa (mono-/di/tri-/tetra-ubiquitin) calculated. Bands ~45-250 kDa represent ubiquitinated proteins containing ser65-phosphorylated Ub. Uncharacterized bands may be observed in some lysate(s).

Immunogen

KLH-conjugated linear peptide corresponding to the ubiquitin target region sequence containing phosphorylated Ser65.

Other Notes

Concentration: Please refer to lot specific datasheet.

Physical form

Affinity purified.
Purified rabbit polyclonal antibody in PBS with 1.5% BSA and 0.05% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of receipt.

Legal Information

ALEXA FLUOR is a trademark of Life Technologies

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yi-Fan Huang et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34(2), 2055-2074 (2020-01-08)
In spinal cord ischemia-reperfusion (I/R) injury, large amounts of reactive oxygen species can cause mitochondrial damage. Therefore, mitophagy acts as the main mechanism for removing damaged mitochondria and protects nerve cells. This study aimed to illustrate the important role of
Matthew G Williamson et al.
Human molecular genetics, 32(18), 2808-2821 (2023-06-29)
Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene have been identified as one of the most common genetic causes of Parkinson's disease (PD). The LRRK2 PD-associated mutations LRRK2G2019S and LRRK2R1441C, located in the kinase domain and in the ROC-COR

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持